Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Breast Cancer Res Treat. 2019 Jul 6;177(3):705–711. doi: 10.1007/s10549-019-05338-1

Fig. 2.

Fig. 2

69-year-old male with family history of breast cancer, tested positive for BRCA2 gene mutation. (a, b, c) Screening mammography of the left breast, medio-lateral oblique (MLO) view, shows predominantly fatty breasts. (a) No suspicious mass or tumor calcifications are seen. Mild asymmetric gynecomastia is present (red circle). BI-RADS 2: benign. Routine annual screening mammography is recommended. (b) There is increasing gynecomastia (red circle), not palpable, for which six month follow-up is recommended. BI-RADS 3: Probably benign. 6 months left breast follow-up is recommended. (c) Left mammogram follow-up. No suspicious mass or tumor calcifications are seen. Left gynecomastia is unchanged (red circle). BI-RADS 2: BENIGN. Routine annual screening mammography is recommended.